News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
290,380 Results
Type
Article (17826)
Company Profile (38)
Press Release (272516)
Section
Business (81509)
Career Advice (164)
Deals (12583)
Drug Delivery (28)
Drug Development (37323)
Employer Resources (20)
FDA (5327)
Job Trends (4188)
News (135803)
Policy (10477)
Tag
2024 BioMidwest Digital (1)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (3)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (2)
2024 Genetown Standard (1)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (2)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (2)
2026 Pharm Country Elite (1)
Academia (645)
Accelerated approval (3)
Adcomms (1)
Allergies (42)
Alliances (22139)
ALS (38)
Alzheimer's disease (427)
Antibody-drug conjugate (ADC) (63)
Approvals (5354)
Artificial intelligence (115)
Autoimmune disease (15)
Automation (7)
Bankruptcy (81)
Best Places to Work (3652)
Biosimilars (29)
Biotechnology (33)
Bladder cancer (40)
Brain cancer (7)
Breast cancer (144)
Cancer (1176)
Cardiovascular disease (75)
Career advice (140)
Career pathing (2)
CAR-T (91)
Cell therapy (205)
Cervical cancer (9)
Clinical research (30640)
Collaboration (408)
Compensation (193)
Complete response letters (6)
COVID-19 (1914)
CRISPR (18)
C-suite (111)
Cystic fibrosis (46)
Data (1187)
Depression (14)
Diabetes (104)
Diagnostics (2094)
Digital health (8)
Diversity (1)
Diversity, equity & inclusion (5)
Drug discovery (39)
Drug pricing (19)
Drug shortages (5)
Duchenne muscular dystrophy (27)
Earnings (23360)
Editorial (7)
Employer branding (2)
Employer resources (18)
Events (51386)
Executive appointments (390)
FDA (5886)
Featured Employer (24)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (400)
Gene editing (42)
Generative AI (5)
Gene therapy (128)
GLP-1 (204)
Government (1356)
Grass and pollen (3)
Guidances (21)
Healthcare (4908)
Huntington's disease (10)
IgA nephropathy (20)
Immunology and inflammation (44)
Indications (15)
Infectious disease (1984)
Inflammatory bowel disease (54)
Inflation Reduction Act (2)
Influenza (34)
Intellectual property (40)
Interviews (30)
IPO (4943)
IRA (6)
Job creations (884)
Job search strategy (126)
Kidney cancer (4)
Labor market (2)
Layoffs (88)
Legal (2370)
Liver cancer (34)
Lung cancer (169)
Lymphoma (117)
Machine learning (1)
Management (5)
Manufacturing (108)
MASH (34)
Medical device (2784)
Medtech (2784)
Mergers & acquisitions (7960)
Metabolic disorders (244)
Multiple sclerosis (51)
NASH (10)
Neurodegenerative disease (39)
Neuropsychiatric disorders (9)
Neuroscience (640)
NextGen: Class of 2025 (1582)
Non-profit (613)
Northern California (1290)
Obesity (104)
Opinion (114)
Ovarian cancer (45)
Pain (43)
Pancreatic cancer (43)
Parkinson's disease (59)
Partnered (6)
Patents (74)
Patient recruitment (42)
Peanut (25)
People (33514)
Pharmaceutical (8)
Pharmacy benefit managers (2)
Phase I (10289)
Phase II (14150)
Phase III (9387)
Pipeline (630)
Podcasts (8)
Policy (17)
Postmarket research (1018)
Preclinical (3667)
Press Release (16)
Prostate cancer (51)
Psychedelics (4)
Radiopharmaceuticals (61)
Rare diseases (165)
Real estate (1714)
Recruiting (9)
Regulatory (7602)
Reports (8)
Research institute (615)
Resumes & cover letters (20)
Rett syndrome (4)
RNA editing (3)
RSV (21)
Schizophrenia (25)
Series A (65)
Series B (85)
Service/supplier (2)
Sickle cell disease (24)
Southern California (1020)
Special edition (3)
Spinal muscular atrophy (54)
Sponsored (7)
Startups (1890)
Stomach cancer (4)
Supply chain (30)
Tariffs (3)
The Weekly (8)
United States (10022)
Vaccines (367)
Venture capitalists (15)
Webinars (7)
Weight loss (51)
Women's health (12)
Date
Today (38)
Last 7 days (259)
Last 30 days (1414)
Last 365 days (15122)
2025 (4480)
2024 (14165)
2023 (13809)
2022 (19327)
2021 (22468)
2020 (19458)
2019 (10501)
2018 (7987)
2017 (14299)
2016 (16881)
2015 (21275)
2014 (15972)
2013 (13473)
2012 (13908)
2011 (13590)
2010 (11865)
Location
Africa (287)
Alabama (16)
Arizona (64)
Arkansas (7)
Asia (17999)
Australia (2674)
California (2844)
Canada (850)
China (219)
Colorado (136)
Connecticut (155)
Delaware (94)
Europe (43159)
Florida (324)
Georgia (98)
Idaho (14)
Illinois (261)
India (9)
Indiana (76)
Iowa (3)
Japan (86)
Kansas (40)
Kentucky (11)
Louisiana (1)
Maine (10)
Maryland (306)
Massachusetts (2180)
Michigan (61)
Minnesota (117)
Missouri (34)
Montana (10)
Nebraska (3)
Nevada (37)
New Hampshire (14)
New Jersey (789)
New Mexico (5)
New York (767)
North Carolina (346)
North Dakota (3)
Northern California (1290)
Ohio (65)
Oklahoma (3)
Oregon (12)
Pennsylvania (483)
Puerto Rico (1)
Rhode Island (8)
South America (529)
South Carolina (4)
Southern California (1020)
Tennessee (33)
Texas (452)
Utah (44)
Virginia (61)
Washington D.C. (25)
Washington State (290)
West Virginia (1)
Wisconsin (40)
290,380 Results for "ferring b v".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Ferring Inc. Receives Health Canada Approval for REBYOTA® (fecal microbiota, live)
March 7, 2025
·
9 min read
Pharm Country
Ferring Pharmaceuticals and Posterity Health Launch New Partnership to Activate Men About Their Fertility
Ferring Pharmaceuticals today launched a new Male Fertility program on Ferring’s Fertility Out Loud platform that empowers men to take the initiative to understand their fertility status.
June 20, 2024
·
4 min read
Press Releases
Pharming Technologies B.V. increases its ownership in Abliva AB (publ) to 92.70 percent
February 21, 2025
·
11 min read
Business
Ferring Pharmaceuticals and SK Pharmteco Enter into Commercial Gene Therapy Manufacturing Deal
Ferring Pharmaceuticals and SK pharmteco today announced an agreement to scale up commercial manufacturing capacity for the drug substance of Ferring’s intravesical non-replicating gene therapy ADSTILADRIN (nadofaragene firadenovec-vncg) for ensuring long-term future supply.
April 18, 2024
·
10 min read
Press Releases
Ferring Highlights Commitment to C. Diff Infection Community on the Second Anniversary of the Launch of REBYOTA® (fecal microbiota, live – jslm)
January 27, 2025
·
7 min read
Press Releases
Genpact Announces Renewed Partnership with Ferring Pharmaceuticals
November 21, 2024
·
2 min read
Press Releases
MilliporeSigma Acquires HUB Organoids Holding B.V., Expands Next-Gen Biology Portfolio
January 7, 2025
·
3 min read
Press Releases
Ferring Advances Three Studies in ADSTILADRIN® (nadofaragene firadenovec-vncg) Clinical Trial Program
December 3, 2024
·
16 min read
Press Releases
MilliporeSigma to Acquire HUB Organoids Holding B.V., Advancing Next Generation Biology Portfolio
December 17, 2024
·
5 min read
Pharm Country
Ferring to Present New Data Analyses at ASPN 2024 for SI-6603, an Investigational Treatment for Lumbar Disc Herniation
Ferring Pharmaceuticals today announced the presentation of two analyses of data at the American Society of Pain and Neuroscience (ASPN) 2024 Annual Meeting, for SI-6603, an investigational therapy intended to treat radicular leg pain associated with lumbar disc herniation (LDH).
June 24, 2024
·
3 min read
1 of 29,038
Next
